Delivery Order SPE2DB24D2010-SPE2DB25FAAGD
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,226.74 for 90 tablets of Januvia 100 mg, with an ultimate completion date of September 10, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $26,162.91 for 1,000 tablets of Januvia 100 mg, a diabetes medication, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $20,394.12 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Januvia 100 mg, a diabetes medication. The contract is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and was competitively awarded without any set-aside designation. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100mg, a diabetes medication, with a ceiling value of $34,637.13. This firm fixed-price delivery order, effective June 2, 2025, with an ultimate completion date of June 3, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen's pharmaceutical distribution facility in Conshohocken, Pennsylvania serves as the place of performance....
- The Defense Logistics Agency awarded a delivery order valued at $15,238.68 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Januvia 100 mg, with a completion date of July 24, 2025. This is a firm fixed-price delivery order issued under a non-competitive, non-set-aside arrangement. The award was processed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 pharmaceutical supply vehicle...
- The Defense Logistics Agency awarded a $15,034.57 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 30, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $36,390.38 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on July 25, 2025, with completion scheduled for July 28, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to the prime contractor. The pharmaceutical product will be delivered to the company's place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $59,928.45 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of 1,000 tablets of Januvia 100 mg. The contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 10, 2025, and will be performed at the contractor's Conshohocken facility. This delivery order is...
- The Defense Logistics Agency awarded a $25,361.92 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, with an ultimate completion date of August 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is listed as...
- The Defense Logistics Agency awarded a delivery order valued at $1,091.46 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes medication. The contract, issued on August 26, 2025, with completion targeted for August 27, 2025, carries firm fixed price terms and involves no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the performing location for this order. This delivery order represents a competitive award under...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FAAGDDelivery Order
The Defense Logistics Agency awarded a $16,090.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, with performance at the vendor's Conshohocken, Pennsylvania facility and completion required by July 10, 2025. This non-set-aside competitive award reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's contract portfolio demonstrates significant federal presence across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. As a major pharmaceutical distributor headquartered in Pennsylvania and registered in the System for Award Management, the company consistently fulfills federal medical supply requirements through open competition, with delivery orders ranging substantially in value. The DLA's planned establishment of Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards indicates continued reliance on experienced vendors like AmerisourceBergen to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.1k | 7/9/25 |